Watch: Kiran Mazumdar-Shaw of Biocon Ltd talk on co's earnings

Watch: Kiran Mazumdar-Shaw on the strong Q4FY18 earnings and recent biosimilars approvals expected to positively impact the business in FY19.
Share this Video
Success
This article has been saved